首页> 外国专利> Use of new and known lignans and neolignans as cathepsin inhibitors, for treatment of cancers, hepatic protectors, preservation of human and animal organs, Alzheimer's, and cosmetic anti-aging preparations

Use of new and known lignans and neolignans as cathepsin inhibitors, for treatment of cancers, hepatic protectors, preservation of human and animal organs, Alzheimer's, and cosmetic anti-aging preparations

机译:新的和已知的木脂素和新木脂素作为组织蛋白酶抑制剂的用途,用于治疗癌症,肝保护剂,人类和动物器官的保存,阿尔茨海默氏病和化妆品抗衰老制剂

摘要

The use of lignans and neolignans as cathepsin inhibitors. An independent claim is also included for compounds of formula (I). [Image] A : a group of formula (i) or (ii); R 1phenyl substituted by 1 - 3 groups selected from OH and CH 3O, or a group of formula (iii) or (iv); R 5phenyl substituted by 1 - 3 groups selected from OH and CH 3O; R 2-CH 2OH; R 3HO-CH 2-CH=CH- or HC(O)-CH=CH-; R 4H or OH. [Image] ACTIVITY : Cytostatic; Hepatotropic; Antiinflammatory; Nootropic; Neuroprotective; Dermatological; Immunosuppressive. MECHANISM OF ACTION : Cathepsin inhibitors.
机译:木脂素和新木脂素作为组织蛋白酶抑制剂的用途。对于式(I)的化合物也包括独立权利要求。 [图像] A:一组式(i)或(ii); R 1苯基被1-3个选自OH和CH 3O的基团或式(iii)或(iv)的基团取代; R 5苯基被1-3个选自OH和CH 3O的基团取代; R 2 -CH 2 OH; R 3HO-CH 2-CH = CH-或HC(O)-CH = CH-; R 4H或OH。 [图像]活动:细胞抑制作用;肝消炎(药;促智;具有神经保护作用;皮肤;免疫抑制。作用机理:组织蛋白酶抑制剂。

著录项

  • 公开/公告号FR2851919A1

    专利类型

  • 公开/公告日2004-09-10

    原文格式PDF

  • 申请/专利权人 LMD;

    申请/专利号FR20030002584

  • 申请日2003-03-03

  • 分类号A61K31/357;A61K31/343;C07D319/20;C07D307/80;C07D407/10;A61P35/00;

  • 国家 FR

  • 入库时间 2022-08-21 22:39:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号